{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:48:12Z","timestamp":1794383292362,"version":"4.9.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R35GM14670"],"award-info":[{"award-number":["R35GM14670"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Optimal antibiotic dosing is challenging in critically ill neonates because of the substantial pharmacokinetic variability, which is influenced by factors such as immature renal function, body composition, and critical illness. The use of extracorporeal therapies adds complexity, making predictions difficult in many cases. Meropenem, a broad-spectrum antibiotic, is commonly used due to resistant gram-negative organisms in neonates; however, dosing guidelines for neonates on CARPEDIEM dialysis are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This is a case of a neonate with liver failure of unclear etiology, who was on CARPEDIEM dialysis and started on meropenem for sepsis due to extended-spectrum beta-lactamase\u2013producing\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      and suspected meningitis. Blood samples were sent to an external laboratory for meropenem concentration measurements, and model-informed precision dosing was used to guide the dosing adjustments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Initially, meropenem was administered at 40 mg\/kg every 8 hours with a 30-min infusion, resulting in exposures that exceeded those required to achieve free concentrations above 4 times the minimum inhibitory concentration for the entire dosing interval (100%\n                      <jats:italic toggle=\"yes\">f<\/jats:italic>\n                      T &gt;4xMIC). The dosing interval was adjusted to every 12 hours to avoid unnecessarily high exposure. The regimen was continued without further complications, and the patient underwent successful liver transplantation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This case highlights the successful application of model-informed precision dosing to individualize meropenem therapy in a critically ill neonate with liver failure on CARPEDIEM dialysis. MIPD is a valuable tool for dose adjustment in patients with unique and unpredictable pharmacokinetics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001382","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T12:00:20Z","timestamp":1758024020000},"page":"701-704","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Precision Dosing of Meropenem in a Neonate on CARPEDIEM Dialysis: A Grand Round"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-3717","authenticated-orcid":false,"given":"Ronaldo","family":"Morales Junior","sequence":"first","affiliation":[{"name":"Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Diseroad","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Hutson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Schuler","sequence":"additional","affiliation":[{"name":"Division of Pathology, Special Chemistry Laboratory, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Rhodes","family":"Hambrick","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio;"},{"name":"Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"},{"name":"Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Tang Girdwood","sequence":"additional","affiliation":[{"name":"Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio;"},{"name":"Center for Acute Care Nephrology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and"},{"name":"Division of Hospital Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"R1-20251107","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1111\/bcp.15308","article-title":"Optimal dose of meropenem for the treatment of neonatal sepsis: dosing guideline variations and clinical practice deviations","volume":"88","author":"Raza","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"R2-20251107","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(14)60799-6","article-title":"Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM)","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"R3-20251107","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1128\/AAC.00712-15","article-title":"Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements","volume":"59","author":"Ulldemolins","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R4-20251107","doi-asserted-by":"crossref","first-page":"e0082222","DOI":"10.1128\/aac.00822-22","article-title":"Population pharmacokinetic meta-analysis and dosing recommendation for meropenem in critically ill patients receiving continuous renal replacement therapy","volume":"66","author":"Peng","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-20251107","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s43440-020-00104-3","article-title":"Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial","volume":"72","author":"Onichimowski","year":"2020","journal-title":"Pharmacol Rep"},{"key":"R6-20251107","doi-asserted-by":"crossref","first-page":"e01909-20","DOI":"10.1128\/AAC.01909-20","article-title":"Population pharmacokinetics and pharmacodynamics of meropenem in critically ill pediatric patients","volume":"65","author":"Saito","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"R7-20251107","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00228-019-02761-7","article-title":"Population pharmacokinetics of meropenem in critically ill children with different renal functions","volume":"76","author":"Rapp","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"R8-20251107","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jcph.601","article-title":"Pharmacokinetics of meropenem in children receiving continuous renal replacement therapy: validation of clinical trial simulations","volume":"56","author":"Nehus","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"R9-20251107","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/phar.2505","article-title":"A guide to therapeutic drug monitoring of \u03b2-lactam antibiotics","volume":"41","author":"Fratoni","year":"2021","journal-title":"Pharmacotherapy"},{"key":"R10-20251107","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/PCC.0000000000003599","article-title":"Pharmacokinetic factors associated with early meropenem target attainment in pediatric severe sepsis","volume":"25","author":"Paice","year":"2024","journal-title":"Pediatr Crit Care Med"},{"key":"R11-20251107","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/jac\/dky128","article-title":"Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies","volume":"73","author":"Germovsek","year":"2018","journal-title":"J Antimicrob Chemother"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:00:44Z","timestamp":1762542044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001382","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"2025-03-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}